Navigation Links
Angioplasty Reduces Long-term Cardiac Risk in Heart Patients With 'silent' Ischemia

When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack survivors with 'silent ischemia', according to a study.

Cardiac ischemia is caused by insufficient blood flow to the heart muscle tissue. Silent ischemia can occur without accompanying signs or symptoms of angina (chest pain due to inadequate supply of oxygen to the heart muscle), but can be detected by electrocardiogram (ECG) and other techniques.

Silent ischemia has been shown to predict adverse prognosis in patients after myocardial infarction (MI, heart attack), coronary artery bypass graft surgery, and PCI, with or without stenting, according to background information in the article. However, the effect of PCI on the long-term prognosis of patients with silent ischemia after a heart attack is not known.

Paul Erne, M.D., of the Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland, and colleagues conducted a randomized, unblinded, controlled trial from May 2, 1991, to February 25, 1997, to determine whether PCI compared with drug therapy improves long-term outcome of asymptomatic patients with silent ischemia after a heart attack.

A total of 201 patients with a recent heart attack, silent myocardial ischemia verified by stress imaging, and one- or two-vessel coronary artery disease took part in the study. Ninety-six patients underwent PCI, and 105 patients received intensive anti-ischemic drug therapy. All patients received 100 mg. per day of aspirin and a statin (cholesterol-lowering) drug. Follow-up ended on May 23, 2006.

Patients in the PCI group experienced 27 major adverse cardiac events during an average follow-up of 10.2 years. During the same period, 67 adverse cardiac events occurred in the anti-ischemic drug group. This corresponds to an absolute event reduction of 6.3 percent per ye
'"/>




Page: 1 2

Related medicine news :

1. Cholesterol Drug Helps After Angioplasty
2. Angioplasty Should be the Standard
3. The Success Rate Of Angioplasty In Female Patients Low
4. Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks
5. Angioplasty death risk reduced by doubling drug dose
6. Angioplasty death risk reduced by doubling drug dose
7. A ray of hope in Angioplasty dilemma
8. Angioplasty plus stenting better than thrombolysis for elderly patients with AMI
9. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
10. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
11. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
Post Your Comments:
(Date:6/3/2015)... (PRWEB) June 03, 2015 For the fourth ... ( http://myclassifiedads.net ), a full-service advertising agency, has been honored ... Chamber of Commerce. , MCA has been selected as a ... The company will be honored at a luncheon sponsored by ... the Tampa Museum of Art. , “This luncheon will include ...
(Date:6/3/2015)... TN (PRWEB) June 03, 2015 On ... around the world will gather in their local communities ... Hundreds of cities across the U.S. and abroad will ... to bring attention to the ongoing challenges of cancer ... a cancer diagnosis can be fruitful, rewarding, and inspiring., ...
(Date:6/3/2015)... Implant design can have a profound influence on the ... an implant surface. The unique triangular-shape of the V3 ... regeneration, resulting in the gain of greater volume of ... more esthetic restorations. , “It’s all in the shape”, ... triangular neck of the V3 provides solid anchorage at ...
(Date:6/3/2015)... First Choice Emergency Room , ... the United States, announced that it is opening its ... , “I am pleased to announce that we ... facility in the San Antonio area,” said Dr. James ... Room. , First Choice Emergency Room is revolutionizing ...
(Date:6/3/2015)... 2015 Fit Body Boot Camp ... program. The company helps thousands of individuals across the country ... people to hit the gym and get the fitness results ... getting the most out any gym membership: , Tip #1 ... to gym memberships is saying motivated and on track. Attempting ...
Breaking Medicine News(10 mins):Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 3
... Nation,s Leading Specialty Toy Retailer Highlights ,Ten Toys That Speak To ... ... This weekend, Toys"R"Us, in,conjunction with the Toys"R"Us Children,s Fund, will kick ... dedicated to facilitating research that will uncover the,causes of, develop treatments for ...
... lupus, can affect nearly any part of the body, ... brain. Along with joint pain, muscle pain, unexplained ... events often accompany this autoimmune disease. Depending on ... patients experience signs and symptoms of neuropsychiatric (NP) disease. ...
... predominant in women, the reasons for this are unclear. ... the risk and severity of RA, but the results ... from the Womens Health Initiative (WHI) clinical trials on ... differences in the risk of developing RA or the ...
... Feb. 28, 2008 UT Southwestern Medical Center ... requiring only a single incision in the bellybutton rather ... is the first such operation in North Texas. , ... Rivas, assistant professor of surgery, who completed the 80-minute ...
... Highlights, - Revenue for the fourth quarter was $469.5 million, up ... $1.8 billion, a 40% ... occupancy for the fourth quarter was 90.6% and for the full year ... for the full year of 2006., - Same store Facility Operating Income ...
... Sirion Therapeutics, Inc., a,privately held ophthalmic-focused ... Application (NDA) for Durezol(TM) has been,accepted by ... and granted,priority review. Sirion Therapeutics is seeking ... Durezol(TM) (difluprednate ophthalmic,emulsion) 0.05%, a twice-daily steroid, ...
Cached Medicine News:Health News:Toys'R'Us Kicks Off Fundraising Campaign to Benefit Autism Speaks 2Health News:Toys'R'Us Kicks Off Fundraising Campaign to Benefit Autism Speaks 3Health News:Autoantibodies and neuropsychiatric events in lupus 2Health News:Autoantibodies and neuropsychiatric events in lupus 3Health News:Hormone replacement therapy appears to have no effect on risk and severity of rheumatoid arthritis 2Health News:UT Southwestern surgeons complete North Texas' first single-incision gallbladder removal 2Health News:UT Southwestern surgeons complete North Texas' first single-incision gallbladder removal 3Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 2Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 3Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 4Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 5Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 6Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 7Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 8Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 9Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 10Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 11Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 12Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 13Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 14Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 15Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 16Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 17Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 18Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 19Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 20Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 21Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 22Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 23Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 24Health News:Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation 2
(Date:6/3/2015)... South 2015 came to a successful conclusion on April 21. ... has been recognized by industry insiders through its professional and ... medical device manufacturing industry in Southern China ... successful return of the MEDTEC brand to Shenzhen ... 2005. , The most ...
(Date:6/3/2015)...   Health Data Consortium (HDC) , a public-private partnership whose mission ... to improve health and healthcare, today announced Niall Brennan ... Office of Enterprise Data and Analytics at the Centers ... of this year,s Health Data Liberators Award ... ways to help improve the quality and value of ...
(Date:6/3/2015)... 2015  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), ... its expertise in opioid antagonists, announced today that ... opioid overdose with intranasal naloxone, has commenced a ... to the United States Food and Drug Administration ... a drug intended to treat opioid overdose.  A ...
Breaking Medicine Technology:MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 2CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 4Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3
... announces that a new market research report is ... Pharmaceuticals Inc.: PharmaVitae Profile ... the historical and forecast performance for Watson in ... company strategy, portfolio and pipeline analysis and assessment ...
... Reportlinker.com announces that a new market research report ... Daiichi Sankyo Co., Ltd: PharmaVitae Profile ... This analysis examines the historical ... prescription pharmaceutical sector. The profile encompasses global company ...
Cached Medicine Technology:Reportlinker Adds Watson Pharmaceuticals Inc.: PharmaVitae Profile 2Reportlinker Adds Daiichi Sankyo Co., Ltd: PharmaVitae Profile 2
... 20-year history, the VOYAGER RX Dilatation Catheter ... outcomes. It combines a new low profile, ... shaft,more flexible markers, and short taper balloon ... tortuous anatomy with even greater confidence, opening ...
... Utilizing technology developed over Guidants 20-year history, ... new foundation for successful treatment outcomes. It ... design with a lower profile shaft,more flexible ... you can cross tight and tortuous anatomy ...
... Utilizing technology developed over Guidants 20-year ... the new foundation for successful treatment outcomes. ... tip design with a lower profile shaft,more ... Now you can cross tight and tortuous ...
The assay is an immunometric ('sandwich') EIA for the quantitative measurement of AFP in human serum or plasma....
Medicine Products: